@article{35a442ffe177465185c8acae75973e43,
title = "Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature",
keywords = "Dosing, JAK2 inhibitor, Platelet count, Safety, Treatment, POLYCYTHEMIA-VERA, OPEN-LABEL, EFFICACY, MULTICENTER, SAFETY, CRITERIA, THERAPY",
author = "Stefanie Slot and Raymakers, {Reinier A. P.} and Nicolaas Schaap and Span, {Lambert F. R.} and Koene, {Harry R.} and Sabina Kersting and Boekhorst, {Peter A. W. te} and Matthijs Westerman and Schouten, {Harry C.} and Sonja Zweegman",
year = "2019",
month = oct,
doi = "10.1016/j.clml.2019.07.005",
language = "English",
volume = "19",
pages = "624--634",
journal = "Clinical Lymphoma Myeloma & Leukemia",
issn = "2152-2650",
publisher = "CIG Media Group, L.P.",
number = "10",
}